We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current HTBX market cap is 10.31M. The company's latest EPS is USD -7.5752 and P/E is -0.01.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.85M | 4.51M | 760k | 1.03M | 1.13M |
| Operating Income | -6.44M | -5.32M | -6.39M | -12.06M | -7.89M |
| Net Income | -5.41M | -4.42M | -6.56M | -12.43M | -9.4M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2.95M | 2.11M | 9.84M | 7M | 7.43M |
| Operating Income | -24.93M | -34.99M | -45.69M | -42.03M | -31.66M |
| Net Income | -26.05M | -35.07M | -43.44M | -45.22M | -32.81M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 51.04M | 50.5M | 46.69M | 46.54M | 39.18M |
| Total Liabilities | 22.74M | 25.25M | 24.83M | 21.99M | 37.5M |
| Total Equity | 28.3M | 25.26M | 21.86M | 24.54M | 1.68M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 124.2M | 120.96M | 104.4M | 51.04M | 39.18M |
| Total Liabilities | 8.7M | 8.93M | 31.96M | 22.74M | 37.5M |
| Total Equity | 115.49M | 112.03M | 72.44M | 28.3M | 1.68M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -31.53M | -4.68M | -11.22M | -20.72M | -26.01M |
| Investing | 32.24M | 2.78M | 3.04M | 2.83M | 1.21M |
| Financing | -8.95M | 3.28M | 9.47M | 22.27M | 25.64M |
| Year End December 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.02M | -38.13M | -5.7M | -31.53M | -26.01M |
| Investing | -95.42M | 9.77M | 10.99M | 32.24M | 1.21M |
| Financing | 119.33M | 25.49M | -4.91M | -8.95M | 25.64M |
| Market Cap | 10.31M |
| Price to Earnings Ratio | -0.01 |
| Price to Sales Ratio | 0.02 |
| Price to Cash Ratio | 0.17 |
| Price to Book Ratio | 0.1 |
| Dividend Yield | - |
| Shares Outstanding | 4.33M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.22 (8.98%) |
| Company Name | Heat Biologics Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://ir.scorpiusbiologics.com/ |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
